Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis.

Kensuke Shoji,Yusuke Asai,Takayuki Akiyama,Shinya Tsuzuki,Nobuaki Matsunaga,Setsuko Suzuki,Noriko Iwamoto,Takanori Funaki,Isao Miyairi,Norio Ohmagari

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy（2023）

引用 3|浏览3

暂无评分

摘要

Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要